Correction to: First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

被引：0

作者：

Mauro Morri

Patricia Castellano

Darío Leonardi

Silvana Vignaduzzo

机构：

[1] Universidad Nacional de Rosario,Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas

[2] Universidad Nacional de Rosario,Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas

[3] IQUIR-CONICET,Área Técnica Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas

[4] Universidad Nacional de Rosario,Facultad de Ciencias Bioquímicas y Farmacéuticas

[5] Universidad Nacional de Rosario,undefined

来源：

AAPS PharmSciTech | 2018年 / 19卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.

引用

页码：3907 / 3907

共 50 条

[41] Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation
Prabagaran Chandrasekaran
Ruckmani Kandasamy
AAPS PharmSciTech, 2017, 18 : 2394 - 2409
[42] Formulation Development of Oral Timed-Release Press-Coated Tablets: Optimization and In Vivo Studies
Narendra, Childkanna
Srinath, Mayasandra S.
LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (06): : 1142 - 1151
[43] Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation
Cheng, Xiang
Han, Xiaoran
Si, Jia
Dong, Cong
Ji, Zhongjuan
Zhao, Shicong
Wu, Xiangting
Li, Haiyan
Jin, Xiangqun
PHARMACEUTICS, 2024, 16 (09)
[44] Development and validation of a capillary electrophoresis method applied to the analysis of l-citrulline in an oral formulation for pediatric use
Javier Salvo, Leandro
Coiana, Lorenzo
Dobrecky, Cecilia
Tripodi, Valeria
Flor, Sabrina
Lucangioli, Silvia
ELECTROPHORESIS, 2019, 40 (12-13) : 1719 - 1721
[45] Development of a pediatric oral solution of ONC201 using nicotinamide to enhance solubility and stability
Annereau, Maxime
Secretan, Philippe-Henri
Vignes, Marina
Ramos, Stephanie
Grill, Jacques
Bizien, Thomas
Sizun, Christina
Michelet, Alexandre
Rieutord, Andre
Legrand, Francois-Xavier
Do, Bernard
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 667
[46] Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
Karsdal, M. A.
Henriksen, K.
Bay-Jensen, A. C.
Molloy, B.
Arnold, M.
John, M. R.
Byrjalsen, I.
Azria, M.
Riis, B. J.
Qvist, P.
Christiansen, C.
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (04): : 460 - 471
[47] Development and validation of a stability-indicating LC method to quantify hydrochlorothiazide in oral suspension for pediatric use
Tagliari, Monika Piazzon
Stulzer, Hellen Karine
Murakami, Fabio Seigi
Kuminek, Gislaine
Valente, Bruno
Oliveira, Paulo Renato
Segatto Silva, Marcos Antonio
CHROMATOGRAPHIA, 2008, 67 (7-8) : 647 - 652
[48] Development and Validation of a Stability-Indicating LC Method to Quantify Hydrochlorothiazide in Oral Suspension for Pediatric Use
Monika Piazzon Tagliari
Hellen Karine Stulzer
Fabio Seigi Murakami
Gislaine Kuminek
Bruno Valente
Paulo Renato Oliveira
Marcos Antonio Segatto Silva
Chromatographia, 2008, 67 : 647 - 652
[49] Solidified Self-Nanoemulsifying Formulation for Oral Delivery of Combinatorial Therapeutic Regimen: Part I. Formulation Development, Statistical Optimization, and In Vitro Characterization
Jain, Amit K.
Thanki, Kaushik
Jain, Sanyog
PHARMACEUTICAL RESEARCH, 2014, 31 (04) : 923 - 945
[50] Solidified Self-Nanoemulsifying Formulation for Oral Delivery of Combinatorial Therapeutic Regimen: Part I. Formulation Development, Statistical Optimization, and In Vitro Characterization
Amit K. Jain
Kaushik Thanki
Sanyog Jain
Pharmaceutical Research, 2014, 31 : 923 - 945

← 1 2 3 4 5 →